OR WAIT null SECS
© 2022 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
May 09, 2022
Home environments have a clear impact on depression treatment outcomes.
May 06, 2022
In this CME, review novel, currently available, and promising pharmacological treatment options for treatment-resistant depression.
May 02, 2022
Zuranolone, a drug for the treatment of major depressive disorder and postpartum disorder, is on a rolling submission of a new drug application.
April 29, 2022
The experts weighed in on a wide variety of psychiatric issues for the April 2022 issue of Psychiatric Times.
April 25, 2022
The most common issues during the COVID-19 pandemic included stress, anxiety.
April 21, 2022
Sidney Zisook, MD, lists these as the top 8 issues in MDD.
Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.
April 15, 2022
Evidence review focuses on bipolar disorder, psychosis, and major depression.
April 07, 2022
Study supports evidence for long-term impairment in memory, executive function.
In this CME, evaluate the treatment options for depression among